Aranha G V, Prinz R A, Freeark R J, Kruss D M, Greenlee H B
Arch Surg. 1982 May;117(5):717-21. doi: 10.1001/archsurg.1982.01380290163029.
A review of 81 patients with pancreatic pseudocyst was conducted to assess the value of different treatment modalities. Resection was associated with 18% mortality (two of 11 patients) and 36% morbidity. In three of nine patients undergoing external drainage a recurrent pseudocyst developed, and in one additional patient, a pancreatic fistula persisted. Internal drainage by cystogastrostomy (21 patients) resulted in 9.5% mortality and 9.5% morbidity, whereas cystojejunostomy (33 patients) was associated with a 6% mortality and 6% morbidity. Endoscopic drainage through the posterior wall of the stomach was unsuccessful in the two patients in which it was used. Internal drainage into the stomach, duodenum, or jejunum is a safe and effective approach for most pseudocysts. Persistent symptoms following surgical treatment were primarily related to failure to recognize multiple cysts and/or pancreatic duct obstruction and dilation characteristic or chronic pancreatitis.
对81例胰腺假性囊肿患者进行了回顾性研究,以评估不同治疗方式的价值。手术切除的死亡率为18%(11例患者中有2例),发病率为36%。9例行外引流的患者中有3例出现复发性假性囊肿,另有1例患者持续存在胰瘘。胃囊肿造瘘术(21例患者)行内引流的死亡率为9.5%,发病率为9.5%,而囊肿空肠吻合术(33例患者)的死亡率为6%,发病率为6%。在2例行经胃后壁内镜引流的患者中,该方法未成功。对大多数假性囊肿而言,内引流至胃、十二指肠或空肠是一种安全有效的方法。手术治疗后持续存在的症状主要与未识别出多个囊肿和/或慢性胰腺炎特有的胰管梗阻及扩张有关。